To explore the mechanism of IGF2BP3 in cervical cancer cells, we overexpressed or silenced IGF2BP3 in cervical cancer cells, and WB experiments were used to verify the expression of EMT biomarker proteins after transfection (Figure 4A). Here, IGF2BP3 is linked to cervical cancer.